Načítá se...
Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma?
Mantle cell lymphoma has been recognized as a distinct entity from the other non-Hodgkin lymphomas in middle 1990's. It carries a worst prognosis among all mature B-cell malignancies. Cyclin D1 and recently SOX11 are the hallmarks for this disease. Even if it is highly responsive to induction t...
Uloženo v:
| Vydáno v: | Contemp Oncol (Pozn) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355653/ https://ncbi.nlm.nih.gov/pubmed/25784834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.45111 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|